ImageneBio, Inc. (IMA) Current Ratio
- Current ratio · latest quarter: Value 21.47×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 21.47× | Current assets / current liabilities. $141.11M ÷ $6.57M ≈ 21.47× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 141.11M USD | Assets, Current |
| Current obligations | 6.57M USD | Liabilities, Current |
| Cash and equivalents | 94.68M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 41.48M USD | Marketable Securities, Current · Debt Securities, Available-for-sale, Current |
| Customer receivables | (m) | |
| Inventory | (m) | |
| Payables | 977.00K USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $141.11M | $6.57M | $94.68M | $41.48M | (m) | (m) | $977.00K | (m) | 21.47× |
| 2026-03-31 | $122.01M | $6.63M | $76.05M | $41.16M | (m) | (m) | $568.00K | (m) | 18.39× |
| 2025-12-31 | $140.29M | $11.23M | $94.53M | $40.82M | (m) | (m) | $1.44M | (m) | 12.49× |
| 2025-09-30 | $147.53M | $11.14M | $103.16M | $39.42M | (m) | (m) | $2.08M | (m) | 13.24× |
| 2025-06-30 | $99.01M | $7.32M | $58.29M | $37.35M | (m) | (m) | $512.00K | (m) | 13.52× |
| 2025-03-31 | $117.00M | $8.79M | $36.76M | $77.29M | (m) | (m) | $805.00K | (m) | 13.31× |
| 2024-12-31 | $12.47M | $17.21M | $12.12M | $0.00 | (m) | (m) | $5.29M | (m) | 0.72× |
| 2024-09-30 | $141.53M | $9.24M | $45.19M | $92.84M | (m) | (m) | $1.54M | (m) | 15.32× |
| 2024-06-30 | $149.32M | $8.20M | $44.27M | $101.15M | (m) | (m) | $1.41M | (m) | 18.22× |
| 2024-03-31 | $161.17M | $10.17M | $52.85M | $104.50M | (m) | (m) | $1.91M | (m) | 15.85× |
| 2023-12-31 | $178.66M | $14.21M | $119.89M | $55.57M | (m) | (m) | $2.07M | (m) | 12.58× |
| 2023-09-30 | $200.63M | $19.27M | $121.28M | $75.66M | (m) | (m) | $3.95M | (m) | 10.41× |
| 2023-06-30 | $160.65M | $12.01M | $70.87M | $86.44M | (m) | (m) | $1.77M | (m) | 13.38× |
| 2023-03-31 | $141.18M | $13.95M | $29.33M | $108.48M | (m) | (m) | $2.76M | (m) | 10.12× |
| 2022-12-31 | $160.01M | $21.50M | $59.92M | $97.03M | (m) | (m) | $2.09M | (m) | 7.44× |
| 2022-09-30 | $177.98M | $25.04M | $67.07M | $107.29M | (m) | (m) | $2.36M | (m) | 7.11× |
| 2022-06-30 | $199.15M | $28.51M | $48.49M | $144.32M | (m) | (m) | $4.09M | (m) | 6.98× |
| 2022-03-31 | $216.05M | $25.33M | $46.88M | $165.50M | (m) | (m) | $2.39M | (m) | 8.53× |
| 2021-12-31 | $236.52M | $27.19M | $232.22M | (m) | (m) | (m) | $2.38M | (m) | 8.70× |
| 2021-09-30 | $251.87M | $30.57M | $245.90M | (m) | (m) | (m) | $1.93M | (m) | 8.24× |
| 2021-06-30 | $268.71M | $30.54M | $264.00M | (m) | (m) | (m) | $2.47M | (m) | 8.80× |
| 2021-03-31 | $283.23M | $30.02M | $281.01M | (m) | (m) | (m) | $2.53M | (m) | 9.44× |
| 2020-12-31 | $165.97M | $28.33M | $162.49M | (m) | (m) | (m) | $2.12M | (m) | 5.86× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |